Clinical Trials Logo

Filter by:
NCT ID: NCT05271721 Recruiting - Chronic Pain Clinical Trials

Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric Comparative Study

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Transforaminal injection of chronic radicular lower limb injection by either dexmedetomdine or magnesuim sulfate

NCT ID: NCT05271461 Recruiting - COVID-19 Pneumonia Clinical Trials

COVID-19 Hyper Coagulability Care by LLLT

LLLT
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

COVID-19 clotting Safety

NCT ID: NCT05269108 Recruiting - Kidney Calculi Clinical Trials

Safety and Efficacy of Fluoroscopy-free Technique During Retrograde Intrarenal Surgery for Renal Stones

Start date: February 25, 2022
Phase: N/A
Study type: Interventional

Aiming to reduce radiation exposure to patients and physicians, the investigators conduct this study protocol to evaluate the possibility of performing retrograde intrarenal surgery (RIRS) under direct visualization without fluoroscopy. the investigators will prospectively evaluate the outcome of fluoroscopy-free RIRS for renal stones in comparison with the standard technique. The investigators expected that the fluoroscopy-free technique has high safety and efficacy even in complicated cases.

NCT ID: NCT05268627 Recruiting - Obesity Clinical Trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Start date: January 27, 2022
Phase: N/A
Study type: Interventional

Background: Obesity is an important public health concern. Surgery is effective but invasive and expensive, and some obese persons are not good surgical candidates. Aim: Compare safety, feasibility and efficacy of endoscopic ultrasound guided boutlinum toxin injection and GLP-1 agonists in treatment of obesity. Methods Full written informed consent will be obtained from all patients.Patient demographics.Detailed medical history.Complete clinical examination.The two methods of intervention will be combined with prescription of several life style modifications as a 2000 kcal diet in men, or 1800kcal in women and moderate daily aerobic exercise (at least 30 minutes, 5 times a week) during 4 months and body weight will be assessed during a 16-week follow-up period.BTA group:Esophagogastroduodenoscopy (EGD) will be done to all subjects under conscious sedation. If no ulceration or retained food, EUS and BTA injection will be performed under the same sedation. EUS examinations will be performed. BTA injections will be made via a 25-gauge EUS needle. A ring of five injections will be made into the gastric antral muscularis propria, 2 to 3 cm proximal to the pylorus. The subjects will receive 20 U at each injection. Subjects will be assessed for complications after recovery from conscious sedation and, again, by telephone the next day.During a 16-week follow-up period after BTA injections, subjects will be weighed weekly.GLP1 group:GLP-1 receptor agonist (Liraglutide subcutaneous once daily).We will start by 0.6 mg daily and we will raise the dose up to 3 mg gradually if patient tolerated.During a 16 week follow up period, subjects will be weighed weekly.

NCT ID: NCT05267847 Recruiting - Pain, Procedural Clinical Trials

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

Start date: February 22, 2022
Phase: N/A
Study type: Interventional

The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

NCT ID: NCT05267691 Recruiting - Clinical trials for Dermatological Tumors

Pathological Characteristics of Basal Cell Carcinoma

Start date: January 1, 2017
Phase:
Study type: Observational

A hospital based cross-sectional study was conducted from 2017 to February 2021. Clinical history, examination and histopathological variants were collected from medical files and pathology reports. Confirmation of pathology was done in all the patients visiting skin and plastic surgery department with suspected lesions.

NCT ID: NCT05266534 Recruiting - Myoma Clinical Trials

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

myomectomy
Start date: December 30, 2021
Phase: N/A
Study type: Interventional

For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.

NCT ID: NCT05265884 Recruiting - Clinical trials for Myofascial Pain Syndrome

Effect of Kinesiotaping on Myofascial Pain Syndrome Post Neck Dissection Surgery

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effect of Kinesio taping on myofascial pain syndrome post neck dissection surgery.

NCT ID: NCT05264025 Recruiting - Clinical trials for Rheumatoid Arthritis

Fexofenadine in Patients With Active Rheumatoid Arthritis

Start date: June 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Rheumatoid arthritis (RA) is an inflammatory autoimmune polyarthritis affecting ∼1% of the world population, resulting in the loss of joint function and progressive structural damage in affected joints. Fexofenadine has been widely used to treat various allergic diseases, like allergic rhinitis, conjunctivitis and chronic idiopathic urticaria. the molecular mechanisms underlying fexofenadine mediated inhibition of TNF-α signalling

NCT ID: NCT05263089 Recruiting - Clinical trials for Proximal Cavities of Posterior Teeth

Clinical Performance of Injectable Universal Flowable Composite in Proximal Cavities of Posterior Teeth.

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the clinical performance of injectable universal flowable composite vs conventional resin composite restorations in proximal cavities of posterior teeth. The null hypothesis is proposed that there will be no difference in the clinical performance of injectable universal flowable composite versus conventional resin composite restorations in proximal cavities of posterior teeth. The design for this randomized controlled clinical trial is a superiority framework with parallel groups with equal allocation ratios. The patients are randomly divided into two groups where one group will receive conventional resin composite and the other group will receive injectable universal flowable resin composite. The restorations will be evaluated for any fracture or loss of retention by using prob following Modified USPHS criteria at baseline, 3, 6, 12 month.